Management of patients with non-small cell lung cancer and poor performance status
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-003-0031-x.pdf
Reference19 articles.
1. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002? CA Cancer J Clin 2002, 52:23–47.
2. Page NC, Read W, Tierney RM, et al.: The epidemiology of small cell lung carcinoma [abstract]? Proc Am Soc Clin Oncol 2002:1216.
3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995, 311:899–909. {cmThis meta-analysis from 52 randomized studies revealed a 10% improvement in the 1-year survival rate of patients with metastatic NSCLC treated with cisplatin containing chemotherapy}.
4. Kelly K, Crowley J, Bunn PA Jr, et al.: Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a Southwest Oncology Group trial? J Clin Oncol 2001, 19:3210–3218.
5. Schiller JH, Harrington D, Belani CP, et al.: Comparison of four chemotherapy regimens for advanced nonsmall cell lung cancer? N Engl J Med 2002, 346:92–98. This large randomized study evaluated four different combination chemotherapy regimens used commonly in metastatic NSCLC. The four chemotherapy regimens produced identical 1-year survival rates of patients.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimens.;Journal of Chemotherapy;2024-08-06
2. American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non–Small Cell Lung Cancer;JAMA Oncology;2024-06-01
3. Comparision of Radiochemotherapy Applications that Committing with Two Different Chemotherapies Route in Locally Advanced Lung Cancer;The Eurasian Journal of Medicine;2020-03-06
4. Effect of Recombinant Human Endostatin on Radiosensitivity in Patients With Non–Small-Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2012-07
5. New Treatment Strategies in Patients with Advanced Non–Small-Cell Lung Cancer and Performance Status 2;Clinical Lung Cancer;2008-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3